Akashi, Japan

Yoshitomo Sakamoto

This inventor holds 1 USPTO granted patent. Top assignee: Kaneka Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshitomo Sakamoto. Retrieved from https://idiyas.com/inventor/yoshitomo-sakamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yoshitomo Sakamoto

Introduction

Yoshitomo Sakamoto is a notable inventor based in Akashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work on coenzyme Q10. His innovative approach has led to advancements in medicinal compositions that enhance absorption after oral administration.

Latest Patents

Sakamoto holds a patent for a pharmaceutical composition comprising coenzyme Q10. This invention aims to provide a medicinal composition that features an enhanced absorption rate, making it more effective for patients. The composition includes the reduced form of coenzyme Q, which accounts for more than 20 weight % of the total coenzyme Q present.

Career Highlights

Yoshitomo Sakamoto is associated with Kaneka Corporation, a company known for its commitment to innovation in the pharmaceutical industry. His work has been instrumental in developing new medicinal formulations that improve patient outcomes.

Collaborations

Sakamoto has collaborated with notable colleagues, including Tatsumasa Mae and Souichi Morikawa. Their combined expertise has contributed to the success of their projects and the advancement of pharmaceutical research.

Conclusion

Yoshitomo Sakamoto's contributions to the field of pharmaceuticals, particularly through his patent on coenzyme Q10, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…